Sleep apnea is a common sleep disorder characterized by frequent interruptions in breathing during sleep. Symptoms include loud snoring and daytime drowsiness. It involves recurring episodes of reduced or halted breathing for short durations while asleep, leading to periodic awakenings and a decline in sleep quality. The market's upward trajectory is propelled by several factors, including the increasing prevalence of sleep apnea and rising awareness about the condition. However, the most significant driver is the continuous stream of technological advancements in sleep apnea devices. These innovations enhance the quality of life for sleep apnea patients and fuel the growth of the USA sleep apnea market, which is poised for substantial expansion in the foreseeable future.
The demand for sleep apnea devices is increasing due to the rising number of diagnosed cases of obstructive sleep apnea (OSA). A wide range of options is available, each designed to cater to specific patient needs. These include CPAP machines, oral appliances, and adaptive servo-ventilation devices. The introduction of advanced, user-friendly devices that offer improved comfort and efficacy is a key driver of market growth.
The main factors driving the sleep apnea devices market in the United States are:
- Rising incidences of sleep apnea
- Rising in the elderly population
- Increasing prevalence of obesity and hypertension
- Growing awareness among patients in the U.S.
More than 5.8 Million adults in the United States are accurately diagnosed with sleep apnea disease. Companies continually invest in R&D to improve device efficacy, comfort, and use. Partnerships and collaborations with healthcare providers and technical innovators are also becoming more frequent tactics for expanding market reach and providing comprehensive solutions.
Home care settings and individuals have a subnational market revenue
Home care settings and individuals are major end users of sleep apnea products in the United States, such as CPAP machines allowing for home therapy. This trend in healthcare towards home-based treatment enables people to manage their conditions without frequent hospitalization or clinic visits, improving compliance and long-term treatment plan adherence. Many insurance policies cover sleep apnea equipment for home use, making it more affordable. Using the equipment at home helps patients integrate therapy into their daily activities, promoting consistent use and improving treatment outcomes. In the United States, the American Sleep Apnea Association is a non-profit organization that raises awareness about sleep apnea, improves treatments, and advocates for the interests of sleep apnea patients.United States Pulse Oximeters Market
Pulse oximeters are commonly used in healthcare to measure hemoglobin oxygen saturation. They are noninvasive and convenient, making them widely used in hospitals. The Pulse oximeters segment is expected to rise due to the increasing prevalence of sleep apnea in the USA. Ongoing developments, such as product launches and partnerships, will further boost the segment. For example, Tyto Care's FDA-cleared fingertip Pulse Oximeter allows for remote checking of blood oxygen saturation levels and heart rate launched in 2021.United States Sleep Apnea Device Company Analysis
ResMed Inc., Carefusion Corp, Somnomed, Koninklijke Philips N.V., Compumedics, Natus Medical Incorporated, Teleflex Incorporated, and Fisher &Paykel Healthcare hold substantial shares in the United States Sleep Apnea Device market.United States Sleep Apnea Device Company News
- Apr 2024, Fisher & Paykel Healthcare launches revolutionary F&P Solo™ Nasal mask for obstructive sleep apnea in the United States.
- In February 2024, ResMed introduced a new bi-level respiratory support device as an alternative to CPAP machines for treating sleep apnea.
- In November 2023, Vivos Therapeutics received clearance from the U.S. health regulator for its oral device to treat severe obstructive sleep apnea (OSA). This marks the first clearance for an oral appliance aimed at treating moderate and severe OSA in adults.
- May 2023, Acurable, a UK-based medical device company, will launch its AcuPebble device for obstructive sleep apnea diagnosis in the USA this summer after securing FDA clearance.
Types - Market breakup from 2 viewpoints:
1. Therapeutic Devices2. Diagnostic Devices
Therapeutic Devices - Market have been further sub segmented from 4 viewpoints:
1. CPAP Sleep Apnea Therapeutic Devices2. Auto CPAP Sleep Apnea Therapeutic Devices
3. BiPAP Sleep Apnea Therapeutic Devices
4. Adaptive Servo-Ventilation (ASV)
Diagnostic Devices - Market have been further sub segmented from 5 viewpoints:
1. Polysomnography Devices (PSG)2. Oximeter
3. Actigraphy Monitoring Device
4. Respiratory Polygraph
5. Sleep Apnea Screening Device
End User - Market breakup from 2 viewpoints:
1. Sleep Laboratories, Clinics & Hospitals2. Home Care Settings/Individuals
All key players have been covered from 3 viewpoints:
- Overview
- Recent Development
- Financial Insight
Company Analysis:
1. ResMed Inc.2. Carefusion Corp
3. Somnomed
4. Koninklijke Philips N.V.
5. Compumedics
6. Natus Medical Incorporated
7. Teleflex Incorporated
8. Fisher & Paykel Healthcare
Table of Contents
Companies Mentioned
- ResMed Inc.
- Carefusion Corp
- Somnomed
- Koninklijke Philips N.V.
- Compumedics
- Natus Medical Incorporated
- Teleflex Incorporated
- Fisher & Paykel Healthcare
Methodology
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 100 |
| Published | June 2024 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value ( USD | $ 2.02 Billion |
| Forecasted Market Value ( USD | $ 3.76 Billion |
| Compound Annual Growth Rate | 7.1% |
| Regions Covered | United States |
| No. of Companies Mentioned | 8 |
